GlassScriptPhysician profile
John Matthew Hassan
NPI 1497721526
$12,835.95
in general payments reported to CMS, 2019-2025
63 companies · $1,226 in 2025
The $1,226 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,507 · 2020: $1,062 · 2021: $1,767 · 2022: $2,140 · 2023: $3,117 · 2024: $2,018 · 2025: $1,226.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,522 · Honoraria: $500 · Travel and Lodging: $338.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,522.09 |
| Honoraria | $500.00 |
| Travel and Lodging | $338.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sn Holdings, LLC | $1,143.00 | 2023 | |
| Sumitomo Pharma America, INC. | $1,007.88 | 2023-2025 | Orgovyx, Gemtesa |
| Janssen Biotech, INC. | $932.53 | 2019-2025 | Erleada, Akeega |
| Pfizer INC. | $849.25 | 2019-2025 | |
| Abbvie INC. | $589.34 | 2019-2025 | |
| Myriad Genetic Laboratories, INC. | $543.53 | 2021-2025 | Prolaris |
| Astellas Pharma US INC | $531.34 | 2019-2024 | Veozah, Myrbetriq |
| Axonics, INC. | $466.01 | 2020-2024 | Axonics |
| Urogen Pharma, INC. | $452.89 | 2020-2025 | Jelmyto |
| Endo Pharmaceuticals INC. | $378.55 | 2019-2022 | |
| Myovant Sciences INC. | $368.78 | 2021-2022 | |
| Allergan, INC. | $289.79 | 2019-2022 | |
| Tolmar Pharmaceuticals, INC. | $270.94 | 2020-2022 | |
| Ferring Pharmaceuticals INC. | $264.98 | 2019-2025 | Adstiladrin |
| Blue Earth Diagnostics | $253.54 | 2019-2023 |
Show all 62 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $250.59 | 2019-2020 | |
| Antares Pharma, INC. | $231.36 | 2019-2025 | Xyosted |
| Neotract INC. | $221.54 | 2019 | |
| Coloplast Corp | $219.07 | 2021-2025 | Speedicath |
| Cardinal Health INC | $202.05 | 2024 | |
| Teleflex LLC | $199.83 | 2021 | |
| Rochester Medical Corporation | $197.42 | 2019-2022 | |
| Laborie Medical Technologies Corp. | $193.01 | 2020-2025 | Urgent PC Neuromodulation System |
| Angiodynamics, INC. | $192.17 | 2022-2024 | Nanoknife |
| Boston Scientific Corporation | $166.27 | 2019-2025 | Rezum Generator, Bulkamid - Bulkamid Urethral Bulking Pack 2ml (Ous) |
| Urovant Sciences INC | $163.41 | 2021-2022 | |
| Medtronic, INC. | $162.96 | 2022-2025 | Interstim |
| Verity Pharmaceuticals INC. | $148.98 | 2022-2025 | Tlando, Trelstar |
| Astellas Pharma Global Development | $141.54 | 2024 | Xtandi |
| Merck Sharp & Dohme LLC | $136.08 | 2019-2024 | Keytruda, Welireg, Lynparza |
| Srs Medical Systems, INC. | $135.46 | 2020 | |
| Janssen Scientific Affairs, LLC | $112.93 | 2019 | |
| 180 Medical, INC. | $107.24 | 2020-2023 | |
| Progenics Pharmaceuticals, INC. | $101.49 | 2021-2023 | Pylarify |
| Comsort, INC | $100.00 | 2019 | |
| Edap Technomed INC | $94.92 | 2019-2024 | |
| Intuitive Surgical, INC. | $90.75 | 2019 | |
| Procept Biorobotics Corporation | $78.94 | 2022-2024 | Aquabeam System |
| Clarus Therapeutics INC. | $73.36 | 2021 | |
| Axogen | $71.08 | 2019-2025 | |
| Convatec INC. | $63.13 | 2022-2023 | |
| Profound Medical Corp. | $60.40 | 2022-2023 | Tulsa-Pro |
| Amgen INC. | $55.81 | 2019-2022 | |
| Ambu INC. | $53.34 | 2024 | |
| C. R. Bard, INC. & Subsidiaries | $48.27 | 2019-2023 | Bard Urinary Drainage Bag |
| Tolmar, INC. | $44.55 | 2023 | |
| Azurity Pharmaceuticals, INC. | $41.57 | 2025 | Azmiro |
| Aytu Biopharma, INC. | $37.16 | 2019 | |
| Novartis Pharmaceuticals Corporation | $32.95 | 2021-2025 | |
| Conmed Corporation | $28.59 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $27.83 | 2023 | Seglentis |
| Accord Healthcare, INC. | $27.62 | 2022 | |
| Becton, Dickinson and Company | $23.29 | 2023 | Bard Urinary Drainage Bag |
| Hollister Incorporated | $20.92 | 2023 | Vapro Pocket |
| Valencia Technologies Corporation | $20.60 | 2025 | Ecoin Device Kit |
| Halozyme INC | $20.13 | 2023 | |
| Clovis Oncology, INC. | $18.57 | 2020 | |
| Olympus America INC. | $17.13 | 2023 | Itind System |
| Astrazeneca Pharmaceuticals LP | $16.77 | 2021 | |
| Novo Nordisk INC | $14.92 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.96 | 2021 | |
| Medtronic USA, INC. | $13.64 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$291,898.13 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Hassan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.